[VRDN] YoY Quarter Result on 31-Dec-2017 [#Q4]

Stock
[VRDN] Viridian Therapeutics, Inc.
Announcement Date
14-Mar-2018
Financial Year
2017
Quarter
31-Dec-2017 [#Q4]
Profit Trend
QoQ- -9.46%
YoY- -14.65%
Quarter Report
VRDN's Result
VRDN's Financial Summary
View:
Show?
Quarter Result
31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 CAGR
Revenue 54 880 476 1,192 756 659 655 -34.00%
PBT -90,742 -10,118 -10,317 -6,386 -5,570 -2,980 -2,258 84.97%
Tax 130 50 289 77 -71 -47 0 -
NP -90,742 -10,118 -10,317 -6,386 -5,570 -2,980 -2,258 84.97%
Tax Rate - - - - - - - -
Total Cost 90,796 10,998 10,793 7,578 6,326 3,639 2,913 77.30%
Ratio Analysis
31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 CAGR
NP Margin -168,040.74 -1,149.77 -2,167.44 -535.74 -736.77 -452.20 -345.00 180.23%
Per Share
31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 CAGR
EPS -23.07 -4.69 -5.02 -4.30 -7.23 -4.19 -5.85 25.66%
EPS Diluted -23.07 -4.69 -5.02 -4.30 -7.23 -4.19 -5.85 25.66%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.